Ocuphire Pharma Shares Rise After First Patients Enroll in Second Phase 3 Pivotal Trial for Nyxol
Ocuphire Pharma, Inc. (NASDAQ: OCUP) shares jumped more than 30% after the biopharmaceutical company announced news regarding the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol® Eye Drops in the reversal of pharmacologically-induced mydriasis...